Abstract
Mounting evidence points to dietary habits as an important determinant of health/disease prevention. Although the linkages with diet are intriguing, the literature is also laden with many inconsistencies. The reasons for these inconsistencies are likely multi-factorial, but probably reflect variation in the ability of bioactive constituents to reach or to influence a specific and critical molecular target(s). Knowledge about three types of biomarkers will assist in comparing the effectiveness of foods and drugs: (1) exposure (amount and time needed to bring about a response), (2) effect (amounts and activity of specific molecular target[s]) and (3) susceptibility determinants (agent-gene interactions or diet-drug interactions). As the era of molecular nutrition unfolds, a greater understanding of how foods and their components influence normal cellular process and ultimately health will surely arise. Knowledge about the molecular targets for bioactive food components may also help explain individuality in response to drugs. Such information will be critical in the development of effective tailored strategies for optimizing health.
Keywords: Dietary, drugs, foods, genes, health, nutrigenomics, targets, omega-3, prebiotic, probiotic
Current Pediatric Reviews
Title:Common Molecular Targets for Bioactive Food Components and Drugs
Volume: 8 Issue: 3
Author(s): John A. Milner
Affiliation:
Keywords: Dietary, drugs, foods, genes, health, nutrigenomics, targets, omega-3, prebiotic, probiotic
Abstract: Mounting evidence points to dietary habits as an important determinant of health/disease prevention. Although the linkages with diet are intriguing, the literature is also laden with many inconsistencies. The reasons for these inconsistencies are likely multi-factorial, but probably reflect variation in the ability of bioactive constituents to reach or to influence a specific and critical molecular target(s). Knowledge about three types of biomarkers will assist in comparing the effectiveness of foods and drugs: (1) exposure (amount and time needed to bring about a response), (2) effect (amounts and activity of specific molecular target[s]) and (3) susceptibility determinants (agent-gene interactions or diet-drug interactions). As the era of molecular nutrition unfolds, a greater understanding of how foods and their components influence normal cellular process and ultimately health will surely arise. Knowledge about the molecular targets for bioactive food components may also help explain individuality in response to drugs. Such information will be critical in the development of effective tailored strategies for optimizing health.
Export Options
About this article
Cite this article as:
A. Milner John, Common Molecular Targets for Bioactive Food Components and Drugs, Current Pediatric Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339612802139424
DOI https://dx.doi.org/10.2174/157339612802139424 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sarcoidosis in Pregnancy and Postpartum Period
Current Respiratory Medicine Reviews Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
Current Pharmaceutical Design The Effect of Flavonoids on Allergic Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Use of Exercise Echocardiography in the Evaluation of Mitral Regurgitation
Current Cardiology Reviews From Raynaud’s Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach
Current Rheumatology Reviews Progress in Development of Group A Streptococcus Vaccines
Current Pharmaceutical Biotechnology Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Editorial [Hot Topic: Waiting for Action on the Osteoarthritis Front (Guest Editors: Virginia Byers Kraus and Thomas Aigner)]
Current Drug Targets Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Comprehensive Profile of <i>Madhuca Longifolia</i> in Pharma and Food Industry
Current Nutraceuticals Moderate Hyperhomocysteinemia and Immune Activation
Current Pharmaceutical Biotechnology Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms
Current Cardiology Reviews Neutrophil F-actin Dynamics in Familial Mediterranean Fever: The Unequal Effect of Colchicine on Activated Neutrophils
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Potential of Selected Indian Herbs for COVID-19
Current Traditional Medicine New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Psoriatic Arthritis – Review of the Immunologic, Clinic and Therapeutic Aspects of an Inflammatory Systemic Disease
Current Rheumatology Reviews Prevention of Ischemic Stroke: Antithrombotic Therapy in Cardiac Embolism
Current Drug Targets